Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model

Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages

(2014) Soo Kyung Jeong et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics

(2013) James H. Finke et al.   CANCER JOURNAL

Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells

(2013) C. Lee-Chang et al.   JOURNAL OF IMMUNOLOGY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Emerging immunotherapies for renal cell carcinoma

(2012) B. Escudier   ANNALS OF ONCOLOGY

Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury

(2012) Sadiye Amcaoglu Rieder et al.   BRITISH JOURNAL OF PHARMACOLOGY

Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma

(2012) Hongbing Guan et al.   PLoS One

Chemosensitization of tumors by resveratrol

(2011) Subash C. Gupta et al.   Annals of the New York Academy of Sciences

Resveratrol and cellular mechanisms of cancer prevention

(2011) Yogeshwer Shukla et al.   Annals of the New York Academy of Sciences

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy

(2011) Brenda L. Soto et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence

(2011) T. E. Hutson   ONCOLOGIST

Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity

(2009) A. Shanker et al.   CANCER RESEARCH

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

(2008) Kiran Gupta et al.   CANCER TREATMENT REVIEWS

Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells

(2008) Yoolhee Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY